Roche: Stefan Frings. Developing personalised cancer care through rational integration of diagnostics and therapeutics Genentech: Mike Crowley. Working with gRED and how that makes Genentech Partnering unique. Telormedix: Johanna Holldack. Focusing on targeted immunity in the treatment of cancer and other diseases e-Therapeutics: Daniel Elger. Pioneers of network pharmacology, a distinctive new approach to the discovery of medicines GSK & Avalon Ventures: Collaborating to invest $495 million in early stage life science companies EMD Serono: Philippe M Lopes-Fernandes. Closure of Geneva site creates opportunities for new business successes TVM Capital: Axel Polack. Investing in developing exciting life science products and companies who aspire to be innovative leaders. AstraZeneca: Morten Faester & Magnus Bjorsne. Tackling Diabetes from a more holistic perspective